| RS193922689 |
FKTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS193922696 |
PRKAG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Lethal congenital glycogen storage disease of heart |
| RS193922697 |
PRKAG2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS193922699 |
RET
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS193922700 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 2A, Multiple endocrine neoplasia |
| RS193922701 |
FGF23
|
Health Risk |
Likely pathogenic |
Autosomal dominant hypophosphatemic rickets, Autosomal dominant hypophosphatemic rickets |
| RS193922702 |
FGF23
|
Health Risk |
Pathogenic |
Autosomal dominant hypophosphatemic rickets, Hypophosphatemic rickets |
| RS193922703 |
AICDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS193922704 |
AICDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS193922705 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Naxos disease, Arrhythmogenic right ventricular cardiomyopathy |
| RS193922706 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Cardiomyopathy |
| RS193922707 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Emery-Dreifuss muscular dystrophy 7 |
| RS193922708 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 11 |
| RS193922709 |
BBS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Bardet-Biedl syndrome |
| RS193922710 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS193922711 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS193922712 |
MYLK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 1 |
| RS193922716 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS193922717 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS193922719 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS193922720 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS193922721 |
STAT3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS193922722 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS193922723 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiac arrhythmia |
| RS193922727 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS193922728 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 5, Cardiac arrhythmia |
| RS193922730 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS193922732 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS193922740 |
CD247
|
Health Risk |
Pathogenic |
Immunodeficiency 25, Immunodeficiency 25 |
| RS193922741 |
CD247
|
Health Risk |
Pathogenic |
Immunodeficiency 25, Immunodeficiency 25 |
| RS193922744 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922746 |
RYR1
|
Health Risk |
Likely pathogenic |
King Denborough syndrome, Malignant hyperthermia |
| RS193922750 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922757 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922758 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia of anesthesia, Malignant hyperthermia of anesthesia |
| RS193922761 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS193922766 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922769 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922771 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, RYR1-related disorder |
| RS193922772 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922774 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS193922778 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922781 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922786 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS193922787 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, King Denborough syndrome |
| RS193922788 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922791 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922792 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS193922797 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922801 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922805 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922807 |
RYR1
|
Health Risk |
Likely pathogenic |
enflurane response - Toxicity, desflurane response - Toxicity |
| RS193922808 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS193922809 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922810 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922812 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922814 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS193922816 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia of anesthesia, RYR1-related disorder |
| RS193922826 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia of anesthesia |
| RS193922837 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Inborn genetic diseases |
| RS193922839 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive distal muscle weakness, Pelvic girdle muscle weakness |
| RS193922842 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922844 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS193922846 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS193922847 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS193922852 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia of anesthesia, Malignant hyperthermia |
| RS193922854 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Congenital multicore myopathy with external ophthalmoplegia |
| RS193922856 |
RYR1
|
Health Risk |
Pathogenic |
Neuromuscular disease, congenital |
| RS193922867 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia of anesthesia |
| RS193922868 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS193922870 |
RYR1
|
Health Risk |
Pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS193922875 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS193922884 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS193922886 |
RYR1
|
Health Risk |
Pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS193922887 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, Central core myopathy |
| RS193922888 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS193922892 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS193922893 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS193922894 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS193922895 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS193922897 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS193922900 |
COMP
|
Health Risk |
Pathogenic |
Multiple epiphyseal dysplasia type 1, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS193922906 |
PRNP
|
Health Risk |
Pathogenic |
Huntington disease-like 1, Inherited Creutzfeldt-Jakob disease |
| RS193922915 |
NEU1
|
Health Risk |
Likely pathogenic |
Sialidosis type 2, Sialidosis type 2 |
| RS193922916 |
APP
|
Health Risk |
Pathogenic |
Alzheimer disease, Alzheimer disease |
| RS193922920 |
KIF22
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia with multiple dislocations, Spondyloepimetaphyseal dysplasia with multiple dislocations |
| RS193922921 |
KIF22
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia with multiple dislocations, Inborn genetic diseases |
| RS193922922 |
KIF22
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondyloepimetaphyseal dysplasia with multiple dislocations, Inborn genetic diseases |
| RS193922926 |
ATXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 1, ATXN1-related disorder |
| RS193922927 |
ATXN2
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis, Spinocerebellar ataxia type 2 |
| RS193922928 |
ATXN3
|
Health Risk |
Pathogenic; risk factor |
Azorean disease, Parkinson disease |
| RS193922929 |
ATXN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 7, ATXN7-related disorder |
| RS193922936 |
FMR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fragile X syndrome, Fragile X syndrome |
| RS193922937 |
AFF2
|
Health Risk |
Pathogenic |
FRAXE, FRAXE |
| RS193922938 |
FXN
|
Health Risk |
Pathogenic |
Friedreich ataxia 1, Friedreich ataxia 1 |
| RS193922941 |
PABPN1
|
Health Risk |
Pathogenic |
Oculopharyngeal muscular dystrophy 1, Oculopharyngeal muscular dystrophy |
| RS1939234862 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1939239442 |
NPHP3;NPHP3-ACAD11
|
Health Risk |
Likely pathogenic |
Renal-hepatic-pancreatic dysplasia, Renal-hepatic-pancreatic dysplasia |
| RS1939280733 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1939281881 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Connective tissue disorder, Avascular necrosis of femoral head |